ArticleJAMA network open2022

Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents.

Rishi J Desai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.